Sorafenib enhances effects of transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis.
about
Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised IndexTransarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysisEfficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study.Skeletal muscle depletion predicts the prognosis of patients with hepatocellular carcinoma treated with sorafenibSorafenib combined with transarterial chemoembolization in patients with hepatocellular carcinoma: a meta-analysis and systematic review.Management of hepatocellular carcinoma: an overview of major findings from meta-analysesImaging Intratumoral Nanoparticle Uptake After Combining Nanoembolization with Various Ablative Therapies in Hepatic VX2 Rabbit Tumors.Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis.Current management of hepatocellular carcinoma: an Eastern perspective.Combination of 5-fluorouracil and 2-morphilino-8-phenyl-4H-chromen-4-one may inhibit liver cancer stem cell activity.DCT015, a new sorafenib derivate, inhibits tumor growth and angiogenesis in gastric cancer models.LB-100 sensitizes hepatocellular carcinoma cells to the effects of sorafenib during hypoxia by activation of Smad3 phosphorylation.NSK-01105 inhibits proliferation and induces apoptosis of prostate cancer cells by blocking the Raf/MEK/ERK and PI3K/Akt/mTOR signal pathways.Concurrent sorafenib therapy extends the interval to subsequent TACE for patients with unresectable hepatocellular carcinoma.The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma.Sorafenib-induced acute-on-chronic liver failure in a patient with hepatocellular carcinoma after transarterial chemoembolization and radiofrequency ablation: A case report.TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trial.Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting.Sorafenib improves lipiodol deposition in transarterial chemoembolization of Chinese patients with hepatocellular carcinoma: a long-term, retrospective study.Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis
P2860
Q33665679-D99FFBEF-495B-406B-A3DB-A6C1FBAF9143Q33710153-72D3A15F-C72E-4823-8E28-F06B00A2259DQ33758258-6AC2E1FF-F1EF-4E5E-A5A6-DB9F2DE42F74Q35722941-0234599E-E772-413C-B372-B484535DE347Q35917459-24F312AC-BDAC-40A5-BBC5-ED471008E343Q36014255-CCF6CB10-2532-4B35-9DDA-248E6E0B4773Q36053235-BB421EF2-C0A7-429E-9BE7-1111530C2019Q36344688-135C7DF5-8A68-40A0-9BBF-1D05A7769556Q38410816-B5B13990-3A53-49B0-8EDD-CA8F8FC7EBAAQ38793468-192251CB-9468-4034-9AF5-C688B2E8529AQ38803566-7D11D518-1200-4BDC-AD49-6FE93C88ED58Q38811806-E8DE29F2-35FB-46C9-9959-750DE205AE84Q38940292-C59C4A44-B1EC-4415-BA93-4A89554A6F8EQ40846805-F5F923E2-1431-4F2B-833F-F3DFB40B77C7Q41172447-CD11DE7E-4057-4DB6-BB00-F58A3BF9B085Q41542341-0FC51BB1-DCF7-4C8C-A55C-561891A3B791Q42199684-A48E74C2-D6A0-4CD8-9927-EAFE28BB44D7Q42706768-57F02AD5-6D88-4547-9908-7D4CD486EA1AQ47160108-EEA5318C-E627-4D04-B7C4-7E853D044548Q58605600-89D8900C-2DF6-44FC-94D4-B154BA623B38
P2860
Sorafenib enhances effects of transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Sorafenib enhances effects of ...... atic review and meta-analysis.
@en
type
label
Sorafenib enhances effects of ...... atic review and meta-analysis.
@en
prefLabel
Sorafenib enhances effects of ...... atic review and meta-analysis.
@en
P2093
P2860
P1476
Sorafenib enhances effects of ...... matic review and meta-analysis
@en
P2093
Ting-Bo Liang
Xue-Li Bai
Yi-Wen Chen
P2860
P2888
P304
P356
10.1007/S00432-014-1684-5
P50
P577
2014-04-26T00:00:00Z